NLM Digital Collections

The rising cost of specialty drugs drove spending increases for people with multiple sclerosis

Collection:
Health Policy and Services Research
Author(s):
Johnson, Bill, author
Contributor(s):
Health Care Cost Institute, issuing body.
Publication:
Washington, DC : Health Care Cost Institute, April 2018
Language(s):
English
Format:
Text
Subject(s):
Drug Costs
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Multiple Sclerosis -- economics
Multiple Sclerosis -- drug therapy
Dihydroorotate Oxidase -- antagonists & inhibitors
Dimethyl Fumarate -- economics
Fingolimod Hydrochloride -- economics
Forecasting
Glatiramer Acetate -- economics
Interferon beta-1a -- economics
Interferon beta-1b -- economics
Humans
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (15 pages))
Illustrations:
Illustrations
NLM Unique ID:
101744756 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101744756